Test–Retest Repeatability of Peripheral Ganglion Uptake on 18 F-DCFPyL PET/CT: Implications for Interpreting Benign Uptake on PSMA PET
Journal of Nuclear Medicine · 12.11.2026 · jnumed.126.272972
DOI: 10.2967/jnumed.126.272972 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 12.11.2026. Verfasst von Asif Moin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Repeatability of uptake in benign structures on prostate-specific membrane antigen PET is unexplored and poorly understood. We used a post hoc analysis of a test-retest cohort to assess repeatability of uptake in peripheral ganglia.
Methods
Twenty-two patients were included. Spheric volumes of interest were manually placed on the cervical and lumbosacral dorsal root ganglia, the cervicothoracic ganglia, and the celiac ganglia. Repeatability was quantified using intraclass correlation coefficient, within-subject coefficient of variation, and Bland-Altman limits of agreement.
Results
Ganglion uptake demonstrated an intraclass correlation coefficient of 0.82 and a within-subject coefficient of variation of 13.1%. Bland-Altman analysis on a relative scale demonstrated that the mean bias was 0.9%, with 95% limits of agreement ranging from -35.8% to 37.6%, broadly comparable to the repeatability of prostate cancer tumors previously reported.
Conclusion
The repeatability of uptake in peripheral ganglia on prostate-specific membrane antigen PET scans is similar to the repeatability of uptake in prostate cancer tumors. As such, isolated changes in uptake cannot be used as de facto evidence of a malignant lesion.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas.
- Moffitt Cancer Center, Tampa Bay, Florida.
- Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
- The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
- Department of Nuclear Medicine, Universitätsklinikum Carl Gustav Carus at the TU Dresden, Dresden, Germany.
- German Cancer Consortium, Dresden, Germany.
Zitieren
APA
Moin, A., Markowski, M. C., Pienta, K. J., Pomper, M. G., Kandathil, A., Bundschuh, R. A., Werner, R. A., Solnes, L. B., Lewis, M., Almaguel, F. G., Gorin, M. A., Islam, M. Z., & Rowe, S. P. (2026). Test–Retest Repeatability of Peripheral Ganglion Uptake on 18 F-DCFPyL PET/CT: Implications for Interpreting Benign Uptake on PSMA PET. Journal of Nuclear Medicine, jnumed.126.272972. https://doi.org/10.2967/jnumed.126.272972
Vancouver
Moin A, Markowski MC, Pienta KJ, Pomper MG, Kandathil A, Bundschuh RA, et al. Test–Retest Repeatability of Peripheral Ganglion Uptake on 18 F-DCFPyL PET/CT: Implications for Interpreting Benign Uptake on PSMA PET. Journal of Nuclear Medicine. 2026:jnumed.126.272972. doi:10.2967/jnumed.126.272972
BibTeX
@article{Moin2026,
author = {Moin, Asif and Markowski, Mark C and Pienta, Kenneth J and Pomper, Martin G and Kandathil, Asha and Bundschuh, Ralph A and Werner, Rudolf A and Solnes, Lilja B and Lewis, Matthew and Almaguel, Frankis G and Gorin, Michael A and Islam, Md Zobaer and Rowe, Steven P},
title = {Test–Retest Repeatability of Peripheral Ganglion Uptake on 18 F-DCFPyL PET/CT: Implications for Interpreting Benign Uptake on PSMA PET},
journal = {Journal of Nuclear Medicine},
year = {2026},
pages = {jnumed.126.272972},
doi = {10.2967/jnumed.126.272972}
}
EUVIMED